Saturday 17 October 2026
Export WORX’s income statement to Excel — free account
SCWorx Corp.
WORX Healthcare Health Information Services
SCWorx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 3.75% from fiscal 2024. In the quarter to June 2026, revenue grew 3.43%, EPS grew 98.4% and free cash flow grew 88.0%, each against the same quarter a year earlier.
1.40
0.61
−30.35%
Follow WORX
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | — | 4 | 4 | 4 | 3 | 4 | 3 | 4 | 4 |
P/S ratio |
0.00 | 58.11 | 4.13 | 3.21 | 2.38 | 2.93 | 1.14 | 0.49 | 0.82 | 0.47 |
Altman Z-Score |
38.21 | 0.87 | 2.86 | (1.89) | (2.80) | (1.76) | (3.28) | (6.71) | (6.47) | (5.04) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
49.33 | (3.08) | (2.11) | (10.97) | (10.28) | (10.01) | (8.80) | (17.36) | (16.09) | (4.28) |
Beneish M-Score |
— | — | — | (7.09) | (5.80) | (4.19) | (3.22) | (5.01) | (1.89) | (4.31) |
P/Operating CF |
(16.67) | (10.28) | (21.81) | (40.16) | 66.88 | (41.10) | (43.76) | (17.90) | (18.33) | (10.42) |
P/B ratio |
1.40 | 1.58 | 0.00 | 2.57 | 2.16 | 2.12 | 0.68 | 0.49 | 0.55 | 0.19 |
Price to Tangible BV |
4.13 | 1.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.04 |
EV/Sales |
0.00 | 58.45 | 4.17 | 3.17 | 2.41 | 3.07 | 1.19 | 0.56 | 0.89 | (0.01) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(7.21) | (2.21) | (59.12) | (3.75) | (13.12) | (13.29) | (8.87) | (2.66) | (2.44) | 0.02 |
EV/FCF |
(7.21) | (2.21) | (59.12) | (3.67) | (12.05) | (12.31) | (7.67) | (2.41) | (2.26) | 0.02 |
Quick Ratio |
16.48 | 0.03 | 0.47 | 0.42 | 0.24 | 0.23 | 0.25 | 0.17 | 0.26 | 2.63 |
Current Ratio |
16.95 | 0.40 | 0.97 | 0.42 | 0.48 | 0.33 | 0.38 | 0.19 | 0.27 | 2.72 |
Net Debt/EBITDA |
1.04 | 0.01 | (7.26) | 0.04 | 0.01 | (0.10) | 0.05 | 0.00 | 0.07 | (1.00) |
Debt/Assets |
0.00% | 0.00% | 52.49% | 0.00% | 2.77% | 4.75% | 1.60% | 1.44% | 0.31% | 0.00% |
Debt/Equity |
0.00 | 0.00 | (6.86) | 0.00 | 0.05 | 0.07 | 0.02 | 0.02 | 0.00 | 0.00 |
Asset Turnover |
0.08 | 0.02 | 0.54 | 0.85 | 0.51 | 0.47 | 0.44 | 0.49 | 0.47 | 0.40 |
Operating CF/Net income |
0.49 | 0.49 | 0.63 | 0.41 | 0.13 | 0.28 | 0.29 | 0.20 | 0.95 | 0.35 |
Capex/Depreciation |
(0.28) | 0.00 | 0.00 | (2.71) | 0.00 | 0.00 | — | — | 0.00 | (0.01) |
Interest Coverage |
— | — | (0.69) | (502.00) | — | — | (663.56) | (226.67) | (12.09) | (0.32) |
| (62.40%) | (109.66%) | (9.63%) | (338.03%) | (116.95%) | (62.85%) | (28.03%) | (74.90%) | (27.24%) | (76.35%) | |
| (59.33%) | (100.87%) | (5.95%) | (173.71%) | (71.80%) | (38.63%) | (20.11%) | (51.29%) | (18.00%) | (62.41%) | |
ROIC |
(33.98%) | (24.49%) | (7.77%) | (115.51%) | (66.85%) | (35.23%) | (19.88%) | (23.54%) | (17.88%) | (10.88%) |
Return on Tangible Assets |
(89.26%) | 1,258.65% | 765.79% | 680.00% | 316.56% | 249.67% | 128.10% | 209.69% | 85.23% | (344.50%) |
Average Days of Receivables |
5.25 | 0.00 | 68.48 | 52.58 | 50.57 | 36.63 | 30.37 | 29.24 | 45.50 | 39.75 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
750.36% | 934.39% | 19.25% | 235.46% | 148.53% | 122.28% | 64.63% | 49.43% | 34.27% | 47.51% |
Intangible Assets out of Total Assets |
0.65 | 0.03 | 0.00 | 0.86 | 0.79 | 0.92 | 0.90 | 0.93 | 0.92 | 0.74 |
Share Based Compensation of Revenue |
447.35% | 234.16% | 21.58% | 134.86% | 63.01% | 58.02% | 28.28% | 9.50% | 11.57% | 4.84% |
Graham Net Nets |
0.24 | (0.08) | (0.12) | (0.10) | (0.22) | (0.14) | (0.34) | (1.06) | (0.55) | 0.95 |
Graham Number |
0.00 | 0.00 | 839.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(20.09%) | (87.95%) | (2.76%) | (72.08%) | (60.11%) | (27.51%) | (33.97%) | (209.04%) | (45.71%) | (330.67%) |
Free Cash Flow Yield |
(10.49%) | (45.44%) | (1.71%) | (26.95%) | (8.42%) | (8.50%) | (13.51%) | (47.44%) | (47.43%) | (115.39%) |
Revenue per Share |
5,914.00 | 1,103.50 | 2,012.88 | 2,412.22 | 1,533.26 | 1,187.82 | 917.77 | 667.53 | 369.09 | 71.23 |
Operating CF per Share |
(20,181.00) | (29,141.50) | (141.82) | (2,039.70) | (282.09) | (274.33) | (122.73) | (141.44) | (133.86) | (38.21) |
Capex per Share |
(1,116.00) | 0.00 | 0.00 | (48.57) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.76) |
Free Cash Flow per Share |
(21,297.00) | (29,141.50) | (141.82) | (2,088.26) | (282.09) | (274.33) | (122.73) | (141.44) | (133.86) | (38.97) |
Cash per Share |
46,785.00 | 214.00 | 84.41 | 212.17 | 110.71 | 18.23 | 56.70 | 16.04 | 13.17 | 40.70 |
Shareholders Equity per Share |
137,118.00 | 40,672.50 | (136.41) | 3,011.13 | 1,686.47 | 1,642.33 | 1,540.11 | 676.04 | 554.27 | 177.04 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
137,118.00 | 40,672.50 | (136.41) | 3,011.13 | 1,686.47 | 1,642.33 | 1,540.11 | 676.04 | 554.27 | 177.04 |
Free Cash Flow |
(2.13) | (5.83) | (0.24) | (4.80) | (0.96) | (1.07) | (0.54) | (0.81) | (1.08) | (1.57) |
Working Capital |
4.54 | (0.95) | (0.05) | (1.77) | (2.41) | (1.53) | (1.44) | (1.90) | (1.33) | 1.28 |
Capital Expenditures |
(0.11) | — | — | (0.11) | — | — | — | — | — | (0.03) |
Net Current Asset Value |
4.54 | (0.98) | (1.64) | (1.77) | (2.71) | (1.96) | (1.59) | (1.99) | (1.35) | 1.28 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
Capex to Sales |
0.19 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
3.25 | 0.00 | 0.00 | 0.39 | 3.07 | 0.00 | — | — | 0.00 | 255.06 |
Cash ROIC |
(11.58%) | (71.27%) | (16.04%) | (64.79%) | (14.98%) | (15.48%) | (7.53%) | (19.98%) | (23.49%) | (17.89%) |
Accounts Receivable Turnover |
0.79 | 0.00 | 10.52 | 7.70 | 6.85 | 7.80 | 10.08 | 11.88 | 8.83 | 8.39 |
Accounts Payable Turnover |
2.28 | 0.00 | 3.43 | 3.06 | 1.88 | 1.68 | 1.69 | 1.49 | 1.37 | 1.99 |
Inventory Turnover |
0.00 | — | 0.00 | 0.00 | 6.09 | 4.82 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
270.05 | 0.00 | 107.18 | 167.47 | 179.01 | 208.11 | 211.11 | 271.77 | 225.73 | 108.74 |
Days of Inventory on Hand |
0.00 | — | 0.00 | 0.00 | 103.67 | 20.54 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.74 | — | 0.33 | 0.72 | 0.76 | 0.59 | 0.40 | 0.32 | 0.34 | 0.34 |
Average Payables |
0.17 | 0.56 | 0.85 | 1.43 | 1.87 | 1.66 | 1.55 | 1.70 | 1.64 | 0.99 |
Average Inventory |
— | — | — | — | 0.58 | 0.58 | — | — | — | — |
Average Assets |
7.01 | 11.88 | 6.39 | 6.51 | 10.31 | 9.88 | 9.19 | 7.76 | 6.31 | 7.12 |
Average Common Equity |
6.67 | 10.92 | 3.95 | 3.35 | 6.33 | 6.07 | 6.59 | 5.31 | 4.17 | 5.82 |
Columns are period end dates